1269606-64-5

Basic information

• Product Name: {4-[2-(4-Fluoro-phenyl)-2-hydroxy-ethyl]-piperazin-1-yl}-pyridin-2-yl-methanone
• Synonyms: {4-[2-(4-Fluoro-phenyl)-2-hydroxy-ethyl]-piperazin-1-yl}-pyridin-2-yl-methanone
• CAS NO: 1269606-64-5
• Molecular Weight: 329.374
• Mol File: 1269606-64-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: {4-[2-(4-Fluoro-phenyl)-2-hydroxy-ethyl]-piperazin-1-yl}-pyridin-2-yl-methanone(CAS DataBase Reference)
• NIST Chemistry Reference: {4-[2-(4-Fluoro-phenyl)-2-hydroxy-ethyl]-piperazin-1-yl}-pyridin-2-yl-methanone(1269606-64-5)
• EPA Substance Registry System: {4-[2-(4-Fluoro-phenyl)-2-hydroxy-ethyl]-piperazin-1-yl}-pyridin-2-yl-methanone(1269606-64-5)

Safety Data

• Hazardous Substances Data: 1269606-64-5(Hazardous Substances Data)

Upstream product

• 389628-28-8 tert-butyl 4-picolinoylpiperazine-1-carboxylate 
• 18511-62-1 4-fluorostyrene oxide 
• 39639-98-0 piperazin-1-yl(pyridin-2-yl)methanone 

Downstream Products

• 1269605-71-1 (4-{2-(4-Fluoro-phenyl)-2-[(pyridin-2-ylmethyl)-amino]-ethyl}-piperazin-1-yl)-pyridin-2-yl-methanone 

Relevant articles and documents

Novel Ethanediamone Hepcidine Antagonists

The present invention relates to novel hepcidin antagonists of formula (I), pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for treatment of disorders in iron metabolism, such as, in particular, iron deficiency diseases and anaemias, in particular anaemias in connection with chronic inflammatory diseases (ACD: anaemia of chronic disease and AI: anaemia of inflammation).